Emedastine
- CAS NO.:87233-61-2
- Empirical Formula: C17H26N4O
- Molecular Weight: 302.41
- MDL number: MFCD00865647
- EINECS: 200-258-5
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-19 15:53:33
What is Emedastine?
Absorption
Ophthalmic use of emedastine usually does not produce measurable plasma concentrations.
Toxicity
Somnolence and malaise have been reported following daily oral administration.
The Uses of Emedastine
Antihistaminic, H1-receptor; asthma prophylactic; anti-allergic.
Indications
For the temporary relief of the signs and symptoms of allergic conjunctivitis.
Background
Emedastine is an antihistamine used in eye drops to treat allergic conjunctivitis.
Definition
ChEBI: 1-Methyl-1,4-diazepane in which the hydrogen attached to the nitrogen at position 4 is substituted by a 1-(2-ethoxyethyl)-1H-benzimidazol-2-yl group. A relatively selective histamine H1 antagonist, it is used as the ifumatate salt for allergic rhinitis, urticaria, and pruritic skin disorders, and in eyedrops for the symptomatic relief of allergic conjuntivitis.
brand name
Emadine (Alcon).
Pharmacokinetics
Emedastine is a relatively selective H1-receptor antagonist.
Clinical Use
Emedastine also is a newer antihistamine used topically in the eye for conjunctivitis. It has very high H1 receptor selectivity characteristics, and it is structurally related to the benzimidazoles, such as astemizole. Inhibition of mast cell release of inflammatory mediators has been noted.
Metabolism
Two primary metabolites, 5-hydroxyemedastine and 6-hydroxyemedastine, are excreted in the urine as both free and conjugated forms. Minor metabolites include the 5'-oxoanalogs of 5-hydroxyemedastine and 6-hydroxy-emedastine and the N-oxide.
Properties of Emedastine
Boiling point: | 446.6±55.0 °C(Predicted) |
Density | 1.15±0.1 g/cm3(Predicted) |
storage temp. | 2-8°C |
solubility | DMSO: 125 mg/mL (413.35 mM); Ethanol: 100 mg/mL (330.68 mM) |
pka | 8.86±0.10(Predicted) |
form | Viscous Liquid |
color | Yellow to brown |
CAS DataBase Reference | 87233-61-2(CAS DataBase Reference) |
Safety information for Emedastine
Computed Descriptors for Emedastine
New Products
4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Mefenamic Acid IP/BP/EP/USP Diclofenac Sodium IP/BP/EP/USP Ornidazole IP Diclofenac Potassium SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
1-Methyl-6-oxo-1,6-dihydropyridazine-3-carbonitrile 98%View Details
99903-60-3 -
88491-46-7 98%View Details
88491-46-7 -
1823368-42-8 98%View Details
1823368-42-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%View Details
25408-95-1 -
2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%View Details
1805639-70-6 -
1784294-80-9 98%View Details
1784294-80-9 -
Lithium ClavulanateView Details
61177-44-4